Optimising Your Pharmacovigilance Activities in Clinical Trials
Add bookmark
Optimising Your Pharmacovigilance Activities in Clinical Trials
Add bookmark
Pharmacovigilance is an important and integral part of clinical research. Elie Magdalani, Regional Manager, Medical and Pharmacovigilance Affairs Egypt and North Africa, Ranbaxy Egypt, joins Andrea Charles from Pharma IQ, to talk about how we can ensure the proactive and proportionate collection of high-quality data relevant to the safety of medicines through risk management and structured data collection. Magdalani discusses how can we effectively manage risk throughout the lifecycle of a product and what strategies pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities.
[inlinead]
Tags:
Elie Magdalani
Ranbaxy Egypt
pharmacovigilance affairs
clinical trials Egypt
Risk Management
structured data collection
pharmacovigilance activities
pharmacovigilance
drug safety
